People also forgetting the R&D claim as well.
Should be getting back close to 7 mill this year. that would cover all other expenses for the year not including the trial.
IXC in a great position cash wise and mgmt not milking the company either which is great cash mgmt.
We will have enough for this phase 3 trial plus a little more.
Twiggy's Invex Therapeutics | The Imminent Coin Flip, page-103
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.463M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72081 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 5755 | 1 |
View Market Depth
| Last trade - 10.04am 17/10/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable